Post by
palinc2000 on Jul 10, 2024 4:47pm
Murky sales report imo
Why dont they break down the sales report with the end demand from partients and variations (plus or minus) in inventories in the sales channels
Gloating over 49% increase in Egrifta sales where most of the increase it seems is purely inventory replesnisment .....Why keep everybody guessing by not providing exact metrics
They have covered their behind by adding"
moving forward we expect sales to align with patient demand now that inventory levels have returned to normal"
Not man enough to be fully transparent .....
I am open to hearing arguments proving that I am reading this wrong
Comment by
juniper88 on Jul 10, 2024 6:34pm
How is this different from any other quarterly report in the last 10 years? The only way for us to know if the increase is "real" is if it continues over the next few quarters. Overall the quarter wasn't bad if they are not doing any inventory manipulation.
Comment by
Trogarzon on Jul 10, 2024 9:36pm
Got some hope back today. They delivered a good Q2 and reinstated guidance. Still bullish on the sortilin platform. The CEO sounded genuine and actually mentioned working for all shareholders. I liked what I saw and heard today.
Comment by
Mannequin on Jul 10, 2024 11:11pm
This is unfortunately a show me company. You showed me today. Good. Now show me again tomorrow. They need to grow momentum now, or they will lose it.
Comment by
Qwerty54321 on Jul 10, 2024 10:09pm
That's how I read it. Drawn to exactly the same sentence.
Comment by
LouisW on Jul 11, 2024 8:04am
According to my valuable experience, they only disclose the seemingly positive part and hide the negative part which would mislead investors.
Comment by
Mannequin on Jul 11, 2024 8:38am
What's the issue fellas? They reaffirmed guidance.
Comment by
palinc2000 on Jul 12, 2024 12:48pm
I meant math and assumptions.. I took Egrifta historical revenues and trend to make a wild guess May be others can offer better inputs
Comment by
juniper88 on Jul 14, 2024 9:13am
So, if the new normal quarterly sales base was $16.2 million last quarter then Q3 could be $17 million and Q4 $17.8 million. If Trogazo sale don't go down then Q3 and Q4 revenue could be about $23 and $24 million. So, just falling short of guidance. But at least we're going in the right direction. Of course, I could be misinterpreting Dubuc's statement.
Comment by
palinc2000 on Jul 15, 2024 6:26am
You are right but how could the new nornal base sales be 16.2million? Connecting the dots to make 16.2 Million is where I have difficulty.... We will know in October when 3 rd Quarter Results are released...
Comment by
juniper88 on Jul 15, 2024 8:28am
I kinda take everything that management says with a grain of salt. As I wrote earlier, the next couple of quarter will either confirm or deny what they are saying now. My instinct says that the actual numbers will come in lower. So, we seem to be on the same page.